TenderlineUK
Procurement Intelligence
Search
Find a TenderAwardedContract details notice
Published 19 Jun 2025, 18:26 BST

Official UK procurement notice

NHS National Framework for Denosumab Injection commencing 1st January 2026

Official notice

Authority: NHS England (Central government)·Consortium: 2 public authorities

Framework agreement2 lotsGoodsOpen procedureAbove thresholdSME suitable
Sectors: Medical Devices & Pharma (33) Delivery: North East (UKC)North West (UKD)Yorkshire & Humber (UKE)
+6 moreEast Midlands (UKF)West Midlands (UKG)East of England (UKH)London (UKI)South East (UKJ)South West (UKK)
Framework ceiling (notional)£57,000,000total for 2 lots · framework ceiling, not attributable revenue · 1 value update
Submissions closed 4 Sept 2025awarded 30 Sept 2025
Awarded to ACCORD-UK LTD +7 more2 awards
Framework period 1 yrends 31 Dec 2026 · up to 31 Dec 2028 with extensions · starts 1 Jan 2026

What is being bought2 lots · detail below

Published requirement description

Project title: NHS National Framework for Denosumab Injection commencing 1st January 2026

Offer reference number: CM/TNS/25/5725

Period of framework: 1 January 2026 to 31 December 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

CM/TNS/25/5725/01 - Regional award for Denosumab Injection:

NOFE: (North of England) 01/01/2026 to 31/12/2026 (12 months)

SOFE: (South of England) 01/01/2026 to 31/12/2026 (12 months)

MAE: (Midlands and East) 01/01/2026 to 31/12/2026 (12 months)

LNW: (London) 01/01/2026 to 31/12/2026 (12 months)

CM/TNS/25/5725/02 - National award for Denosumab Injection:

7NAT (National) 01/01/2026 to 31/12/2026 (12 months)

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

NOTE: Please see Attached Contract Copy document for the list of Unsuccessful Suppliers.

CPV: Pharmaceutical products

How this framework works

From the published notice
Type
Closed framework
Call-offs
every call-off is a further competition among the appointed suppliers
Bids received
13 bids on the busiest of 2 lots · 8 suppliers appointed
Framework period
1 yr · up to 3 yrs from 1 Jan 2026
Published description of the framework

Please refer to the ITO Documents for the Operation Description

Lots and requirements (2)Procurement structure

2 lots · all with a published value · same evaluation weights on every lot
Lot #1CM/TNS/25/5725/01 - Regional award for Denosumab InjectionAwardedRenewal 1 yrSMEPublished value£36,000,000

CM/TNS/25/5725/01 - Regional award for Denosumab Injection:

NOFE: (North of England) 01/01/2026 to 31/12/2026 (12 months)

SOFE: (South of England) 01/01/2026 to 31/12/2026 (12 months)

MAE: (Midlands and East) 01/01/2026 to 31/12/2026 (12 months)

LNW: (London) 01/01/2026 to 31/12/2026 (12 months)

Contract period: 1 Jan 2026 – 31 Dec 2026 (1 yr) · up to 31 Dec 2028 with extensionsValue: £36,000,000 exc. VAT · £43,200,000 inc. VAT
Delivery: North East, North West, Yorkshire & Humber, East Midlands, West Midlands, East of England, London, South East, South WestEligibility: SME eligible
Extensions: Option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
33600000 Pharmaceutical products
Lot #2CM/TNS/25/5725/02 - National award for Denosumab InjectionAwardedRenewal 1 yrSMEPublished value£21,000,000

CM/TNS/25/5725/02 - National award for Denosumab Injection:

7NAT (National) 01/01/2026 to 31/12/2026 (12 months)

Contract period: 1 Jan 2026 – 31 Dec 2026 (1 yr) · up to 31 Dec 2028 with extensionsValue: £21,000,000 exc. VAT · £25,200,000 inc. VAT
Delivery: North East, North West, Yorkshire & Humber, East Midlands, West Midlands, East of England, London, South East, South WestEligibility: SME eligible
Extensions: Option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
33600000 Pharmaceutical products

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored · same split on all 2 lots
Price: 100%
Published sub-criteria (1)
  • Price is not the only award criterion: 100%
Published award criteria (1)
  • Price is not the only award criterion
What this means for your bid
  • Price carries 100 of 100 points: a 10% discount moves about 10 points. This one is won on the number: sharpen the price before polishing the prose.
  • “NHS National Framework for Denosumab Injection commencing 1st January…” is a framework: the contest is a place on its panel, not a single contract: each call-off is a further competition, so the pricing contest starts after appointment.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record
Procedure method
Open procedure
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
19 Jun 2025, 18:26 BST
Last source update
4 Dec 2025, 17:53 GMT
Award evaluation window
Submission end – 1 Oct 2025
Authority reference
C370255
FTS notice number
2025/S 000-047020
Latest notice
Contract details notice (UK7)
Classification (CPV)
Pharmaceutical products
Delivery area
North East (UKC)North West (UKD)Yorkshire & Humber (UKE)East Midlands (UKF)West Midlands (UKG)East of England (UKH)London (UKI)South East (UKJ)
+1 moreSouth West (UKK)
Official registry OCID
ocds-h6vhtk-05506a Find a Tender

How it was run

Official notice
Run through: Atamis legacy domain (health-family.force.com) · Who buys & how to bid on Atamis
Supplier login requiredElectronic submission allowedLanguage: EN
Access & registration note: Legacy Salesforce domain still used in notices — use the current Atamis portal · this portal address is a legacy domain; the operator has migrated
Appointment period ends
4 Sept 2025, 13:00 BST
Clarification deadline
28 Aug 2025, 23:59 BST
Submission channel
Official e-sourcing portal
Electronic submission
Allowed
Accepted languages
en
Detailed submission instructions & authority contactsFrom official release

The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗

Additional info obtained from the abovementioned address

Tenders must be submitted to the abovementioned address.

Timeline

19 Jun 2025 → 1 Jan 2026 · 11 dates
  1. Planning notice published
    19 Jun 2025, 18:26 BST
  2. Market engagement
    8 Jul 2025, 23:59 BST

    NHS England is seeking to engage with suppliers that are planning to launch denosumab 60mg and/or 120mg injection. Interested suppliers will be invited to a virtual 1:1 preliminary market engagement meeting on 3rd July 2025. The purpose of these sessions is to update suppliers regarding timelines and to discuss product details including presentation, product launches during the proposed framework period, tender structure, and KPI's. Please contact [email protected] or [email protected] to register your interest in tendering for this framework.

  3. Next notice expected
    30 Jul 2025, 23:59 BST
  4. Tender notice published
    7 Aug 2025, 16:03 BST
  5. Clarification questions by
    28 Aug 2025, 23:59 BST
  6. Admission / appointment period endsperiod end, not a bid countdown
    4 Sept 2025, 13:00 BST
  7. Assessment summaries sent385 days ago
    1 Oct 2025, 00:00 BST
  8. Award decision expected by384 days ago
    1 Oct 2025, 23:59 BST
  9. Standstill ends372 days ago
    13 Oct 2025, 23:59 BST
  10. Latest notice published320 days ago
    4 Dec 2025, 17:53 GMT
  11. Contract starts293 days ago
    1 Jan 2026

Notice history

12 events · 4 releases on Find a Tender · since 19 Jun 2025
  1. Preliminary market engagement notice published
    19 Jun 2025, 18:26 BST
    UK2
  2. Tender notice published
    7 Aug 2025, 16:03 BST
    UK4
  3. Published value updated to £57,000,000
    7 Aug 2025, 16:03 BST
    was £120,000,000
  4. Status changed to active
    7 Aug 2025, 16:03 BST
  5. Procurement method changed
    7 Aug 2025, 16:03 BST
  6. Deadline published: 4 Sept 2025, 13:00 BST
    7 Aug 2025, 16:03 BST
  7. Buyer details updated
    7 Aug 2025, 16:03 BST
  8. Contract award notice published
    2 Oct 2025, 08:29 BST
    UK6
  9. Status changed to complete
    2 Oct 2025, 08:29 BST
  10. Contract signature expected
    23 Oct 2025, 23:59 BST
    scheduled
  11. Contract details notice published
    4 Dec 2025, 17:53 GMT
    UK7
  12. Buyer details updated
    4 Dec 2025, 17:53 GMT
Routine re-releases (4)
  • 2025-06: 1 release · 19 Jun 2025

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 82 awards · see the list ↓
Bids received 133 from SMEs · busiest of 2 lots
Named bidders 13published on the award notice
Contracts signed 2latest 5 Nov 2025
Awarded toValueDateStatus
Lot 1 · CM/TNS/25/5725/01 - Regional award for Denosumab Injection1 award
ACCORD-UK LTD, Biosimilar Collaborations Ireland Limited, Celltrion Healthcare United Kingdom Limited, Gedeon Richter UK LtdSME, Teva UK Ltd, Zentiva Pharma UK LtdSMELot 1 - CM/TNS/25/5725/011 Jan 2026 – 31 Dec 2026 · up to 31 Dec 2028Extensions: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.£37,694,00030 Sept 2025Awarded
Lot 2 · CM/TNS/25/5725/02 - National award for Denosumab Injection1 award
Amgen Ltd, Fresenius Kabi LimitedLot 2 - CM/TNS/25/5725/021 Jan 2026 – 31 Dec 2026 · up to 31 Dec 2028Extensions: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.£15,059,00030 Sept 2025Awarded

Contracts

Bid statistics published by the authority

LotBidsSMEVCSEValid bid range
1 · CM/TNS/25/5725/01 - Regional award for Denosumab Injection13final-stage tenders30—
2 · CM/TNS/25/5725/02 - National award for Denosumab Injection2final-stage tenders00—

Who bid

Bidders as named on the Procurement Act 2023 award notice. “Won” means the bidder holds an award on this notice.

Contracting authority & participating public bodies

2 public bodies on the notice

NHS ENGLAND

Contracting authorityPublic authority - central government GB-NHS: X24 · GB-PPON: PDPT-3135-BWWY NHS England, 7&8 Wellington Place, Leeds, Yorkshire & Humber, LS1 4APContact name, email

Framework contractors & participating bidders

13 commercial parties on the notice · 8 awarded
  • Accord-UK LtdFramework contractorGB-COH: 00079585GB-PPON: PBTN-3137-DHTG Whiddon Valley, Devon, South West, EX32 8NSContact email
  • Amgen LtdFramework contractorGB-COH: 02354269GB-PPON: PDJG-8184-TCQQ 216 Cambridge Science Park, Cambridge, East of England, CB4 0WAContact email
  • Biosimilar Collaborations Ireland LimitedFramework contractorGB-PPON: PQQC-5869-LMVX Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13, DUBLIN, IE, D13 R20R, IEContact email
  • Celltrion Healthcare United Kingdom LimitedFramework contractorGB-COH: 11685363GB-PPON: PYQL-4248-PXXY The Charter Building, Uxbridge, London, UB8 1JGContact email
  • DR REDDY'S LABORATORIES (UK) LIMITEDBidder / tendererGB-COH: 01729064GB-PPON: PGGG-3877-XTJG 410 Cambridge Science Park Milton Road, Cambridge, East of England, CB4 0PE
  • Fresenius Kabi LimitedFramework contractorGB-COH: 02182135GB-PPON: PZVH-4892-PJYY Cestrian Court, Runcorn, North West, WA7 1NTContact email
  • Gedeon Richter UK LtdFramework contractorGB-COH: 04325685GB-PPON: PVNN-9371-ZTBW 127 Shirland Road, London, London, W9 2EPContact email
  • SAMSUNG BIOEPIS UK LIMITEDBidder / tendererGB-COH: 08840722GB-PPON: PNBG-7778-YPZQ 5th Floor, Profile West, Brentford, London, TW8 9ES
  • SANDOZ LIMITEDBidder / tendererGB-COH: 01547204GB-PPON: PNQL-1548-CYBZ Maxis 1, Western Road, Bracknell, South East, RG12 1RF
  • THERAMEX HQ UK LIMITEDBidder / tendererGB-COH: 10944626GB-PPON: PCTP-5926-RNJM 5th Floor 50 Broadway, London, London, SW1H 0BL
Show 3 more suppliers
  • THORNTON & ROSS LIMITEDBidder / tendererGB-COH: 00185947GB-PPON: PWYH-6892-QYNN Linthwaite Labs Manchester Road, Huddersfield, Yorkshire & Humber, HD7 5QH
  • Teva UK LimitedFramework contractorGB-COH: 00302461GB-PPON: PWDD-6894-DXRM Ridings Point, Castleford, Yorkshire & Humber, WF10 5HXContact email
  • Zentiva Pharma UK LtdFramework contractorGB-COH: 02158996GB-PPON: PJTB-3347-PLGW 12 New Fetter Lane, London, London, EC4A 1JPContact email

Official documents & specifications (9)

Official links; attachments are not copied

Tender pack and attachments

Notices published for this procedure